Mbx Biosciences
(NASDAQ) MBX
Mbx Biosciences Financials at a Glance
Market Cap
$1.57B
Revenue (TTM)
$0.00
Net Income (TTM)
$86.97M
EPS (TTM)
$-2.42
P/E Ratio
-13.64
Dividend
$0.00
Beta (Volatility)
1.59 (High)
Dividend
$0.00
Beta (Volatility)
1.59 (High)
Price
$33.21
Volume
20,584
Open
$31.84
Price
$33.21
Volume
20,584
Open
$31.84
Previous Close
$33.21
Daily Range
$31.16 - $33.61
52-Week Range
$4.81 - $44.89
Dividend
$0.00
Beta (Volatility)
1.59 (High)
Price
$33.21
Volume
20,584
Open
$31.84
Previous Close
$33.21
Daily Range
$31.16 - $33.61
52-Week Range
$4.81 - $44.89
MBX News
MBX: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Mbx Biosciences
Industry
Pharmaceuticals
Sector
Health CareEmployees
63
CEO
Peter Kent Hawryluk, MBA
Website
www.mbxbio.comHeadquarters
Carmel, IN 46032, US
MBX Financials
Key Financial Metrics (TTM)
Gross Margin
0%
Operating Margin
0%
Net Income Margin
0%
Return on Equity
-28%
Return on Capital
-27%
Return on Assets
-23%
Earnings Yield
-7.33%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$1.57B
Shares Outstanding
47.51M
Volume
20.58K
Short Interest
0.00%
Avg. Volume
631.97K
Financials (TTM)
Gross Profit
$248.00K
Operating Income
$98.06M
EBITDA
$98.06M
Operating Cash Flow
$79.95M
Capital Expenditure
$1.93M
Free Cash Flow
$81.88M
Cash & ST Invst.
$373.70M
Total Debt
$596.00K
Mbx Biosciences Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonCurrently no data to display.
Earnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$0.00
N/A
Gross Profit
$60.00K
N/A
Gross Margin
0.00%
N/A
Market Cap
$1.57B
N/A
Market Cap/Employee
$36.45M
N/A
Employees
43
N/A
Net Income
$22.06M
-41.6%
EBITDA
$25.73M
-38.7%
Quarterly Fundamentals
Net Cash
$373.11M
+42.4%
Accounts Receivable
$2.12M
+210.9%
Inventory
$0.00
N/A
Long Term Debt
$424.00K
N/A
Short Term Debt
$172.00K
+0.6%
Return on Assets
-22.58%
N/A
Return on Invested Capital
-26.53%
N/A
Free Cash Flow
$19.09M
-18.4%
Operating Cash Flow
$18.30M
-14.1%